Drug Trial Radar · NCT07073547
A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)
Last checked: Nov 19, 2026Latest source record: Sep 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
40
Planned (sponsor's estimate)
Start
Jul 31, 2025
Primary completion
May 26, 2028
Study completion May 26, 2028
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Jul 18, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an interventional, modular, open-label, multicenter study to primarily evaluate the safety and tolerability of AZD0120 in adult participants with multiple myeloma (MM).
Conditions
- Multiple Myeloma
Interventions
AZD0120Biological
AZD0120 is a BCMA/CD19 dual CAR T cell product under investigation for early-line treatment in subjects with multiple myeloma
Primary outcomes
What the sponsor says the trial is designed to measure.
- Adverse Events (AEs)Time frame: 2 years
- Serious Adverse Events (SAEs)Time frame: 2 years
- Dose Limiting Toxicities (DLT)Time frame: 28 days
Locations
13 sites in 1 country. Site status is shown where the registry gives one.
Research Site
Phoenix, Arizona · Withdrawn
Research Site
Duarte, California · Recruiting
Research Site
Denver, Colorado · Recruiting
Research Site
Tampa, Florida · Active not recruiting
Research Site
Atlanta, Georgia · Recruiting
Research Site
Iowa City, Iowa · Recruiting
Research Site
Rochester, Minnesota · Withdrawn
Research Site
St Louis, Missouri · Recruiting
Research Site
New York, New York · Recruiting
Research Site
Nashville, Tennessee · Recruiting
Research Site
Dallas, Texas · Withdrawn
Research Site
Houston, Texas · Recruiting
Research Site
Charlottesville, Virginia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.